AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bdiclo SP 50mg/325mg/15mg Tablet

Prescription Icon
Prescription Required

Marketer

Biosafe Formulations

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)

Overview Bdiclo SP 50mg/325mg/15mg Tablet

Diclofenac, Paracetamol, and Serratiopeptidase tablets (50mg/325mg/15mg) offer relief from moderate pain and fever. This medication is effective for various ailments including muscular, back, and joint pain, menstrual discomfort, and dental pain. Ingestion with food minimizes stomach upset. Dosage and treatment length are determined by individual needs and response. Continue using the medication as prescribed, even after symptom improvement, unless instructed otherwise by your physician. Common, mild side effects may include nausea, vomiting, abdominal pain, indigestion, and heartburn; persistent or worsening side effects warrant immediate medical attention. Minimize dosage while effectively managing symptoms. Inform your doctor about pre-existing medical conditions or concurrent medications, as interactions are possible. Caution is advised for individuals with liver or kidney disease, or alcohol dependence. Pregnant or breastfeeding individuals should seek medical consultation prior to use.

Uses of Bdiclo SP 50mg/325mg/15mg Tablet

Analgesia

Major Benefits of Bdiclo SP 50mg/325mg/15mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bdiclo SP 50mg/325mg/15mg tablets should be administered with a meal.

Common Side effects of Bdiclo SP 50mg/325mg/15mg Tablet:

  • Nausea
  • Vomiting
  • Stomach pain
  • Indigestion
  • Heartburn
  • Loss of appetite
  • Diarrhea

How to use Bdiclo SP 50mg/325mg/15mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Bdiclo SP 50mg/325mg/15mg tablets should be administered with a meal.

How Bdiclo SP 50mg/325mg/15mg Tablet works:

Each Bdiclo SP 50mg/325mg/15mg tablet combines diclofenac, paracetamol, and serratiopeptidase for pain relief. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol, suppress pain and fever signals in the brain. Serratiopeptidase, a proteolytic enzyme, aids healing by targeting and dissolving abnormal proteins at inflammatory sites.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Bdiclo SP 50mg/325mg/15mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Bdiclo SP 50mg/325mg/15mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Bdiclo SP 50mg/325mg/15mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Bdiclo SP 50mg/325mg/15mg Tablets may lead to adverse reactions, such as headaches, blurred vision, dizziness, or drowsiness. These effects could impair your driving ability.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Bdiclo SP 50mg/325mg/15mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Bdiclo SP 50mg/325mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Bdiclo SP 50mg/325mg/15mg tablets are contraindicated in individuals with severe or active liver disease.

What if you forget to take Bdiclo SP 50mg/325mg/15mg Tablet :

Should you forget a Bdiclo SP 50mg/325mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bdiclo SP 50mg/325mg/15mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medications for pain relief

FAQs on Bdiclo SP 50mg/325mg/15mg Tablet

Maintain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Each Bdiclo SP 50mg/325mg/15mg tablet combines diclofenac, paracetamol, and serratiopeptidase to alleviate pain and inflammation. The medication achieves this effect by reducing the concentration of pain- and inflammation-inducing chemicals within the body.
Bdiclo SP 50mg/325mg/15mg Tablets are generally well-tolerated; however, some individuals may experience minor adverse reactions such as nausea, vomiting, abdominal discomfort, heartburn, or diarrhea. Report any ongoing issues related to this medication to your physician promptly.
The combination medication Bdiclo SP 50mg/325mg/15mg Tablet is typically prescribed for short-term pain management and may be stopped once pain subsides. Nevertheless, your doctor may recommend continued use of Bdiclo SP 50mg/325mg/15mg Tablet.
Nausea and vomiting are possible side effects of Bdiclo SP 50mg/325mg/15mg Tablets. Consuming the tablets with milk, food, or antacids may mitigate nausea. Refrain from consuming fatty or fried foods concurrently. If vomiting occurs, replenish fluids by sipping small amounts of water frequently. Consult your physician if vomiting continues or if dehydration symptoms, such as dark, strong-smelling urine and infrequent urination, appear. Do not use other medications without your doctor's approval.
Indeed, $ame may induce dizziness in certain individuals, manifesting as faintness, weakness, unsteadiness, or lightheadedness. Should dizziness or lightheadedness occur, rest is recommended until symptoms subside. Operating machinery or driving should be avoided during such episodes.
Patients with hypersensitivity to any Bdiclo SP 50mg/325mg/15mg Tablet constituent or to other nonsteroidal anti-inflammatory drugs (NSAIDs) should not take this medication. Individuals with a history of peptic ulcers, active or recurrent stomach ulceration/bleeding, heart failure, hypertension, or hepatic or renal impairment should ideally refrain from using this product.
Concurrent use of Bdiclo SP 50mg/325mg/15mg tablets and vitamin B-complex supplements is permissible. The tablet offers pain relief, while the vitamin supplement addresses potential vitamin deficiencies contributing to the patient's discomfort.
Bdiclo SP 50mg/325mg/15mg tablets are not recommended for self-treatment of stomach pain. Consult a doctor before using this medication, as it can stimulate gastric acid production, potentially worsening undiagnosed issues.
Exceeding the prescribed dosage of Bdiclo SP 50mg/325mg/15mg tablets elevates the risk of adverse reactions. Should your pain worsen or fail to respond to the recommended dose, seek medical advice for reassessment.
Bdiclo SP 50mg/325mg/15mg...
53
MRP 65
18% off